A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/10910058

Cancer Res. 2000 Jul 1 60 13 3470-6

Download in:

View as

General Info

PMID
10910058